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Adequate replacement therapy in haemophilia has been available for two decades. This
has led to considerable improvements in the life expectancy and physical Status of
haemophilia patients. A study was conducted to investigate whether this has also led to
improvements in quality of life. With this aim, Information was obtained from 935 Dutch
haemophiliacs by mailed questionnaires on relationships, marriage, family life and
employment. Haemophilia patients were less often married than men in the general
Population (13% fewer) and had a lower total number of children (30% lower, 17% for
those who were married). Twenty-two per cent of the patients were not employed and
received an income from the disability funds. While severity of haemophilia, joint damage
and age increased the risk of disability, it was noted that home treatment was associated
with a 50% reduction in this risk. Remarkably, haemophilia patients did not differ from
the general population in their view of the quality of their own health. The results of this
study show a positive influence of modern haemophilia treatment on quality of life. At
present, AIDS overshadows all optimistic feelings one may have about this field. However,
the results described here demonstrate the benefits that can be achieved with adequate
replacement therapy, and justify the expectation of further improvements in the near
future.
Keywords: employment, family life, haemophilia, home treatment, inhibitors, quality of
life.
Introduction
Clotting factor preparations for the treatment of
haemophilia A and B have been used in the
Netherlands since the late 1960s [1-4]. Since then,
the use of coagulation products has steadily increased
[5-7], enhanced by the introduction of prophylaxis
[8, 9] and home treatment [10, 11]. The availability
of effective treatment has led to substantial improve-
ments in the health Status of patients with hae-
mophilia. Life expectancy, which was less than 30
years in 1960, is now almost normal [12-14]. The
number and duration of hospital admissions have
declined sharply, äs has the extent of sick leave from
school and work [12].
The purpose of the present study was to investigate
whether these improvements have also led to an
improved quality of life for haemophilia patients.
Quality of life can be broadly defined äs the degree of
satisfaction with life in general [15, 16]. This may be
reduced in haemophiliacs because of the acute Symp-
toms of a bleeding, chronic arthropathy, or because
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of prejudice towards patients with a genetic bleeding
disorder [17].
Quality of life may be judged externally by objective
Parameters or subjectively by the individual himself
[18]. We used both approaches. Since most people
consider good health to be of paramount importance
in securing a high quality of life [19], we investigated
the patients' subjective Interpretation of their own
health and compared this with the view of the
general population.
Objectively, the physical Status of haemophilia
patients has been greatly improved by replacement
therapy. We studied the extent to which this im-
proved physical Status has affected other aspects of
life that are generally perceived to be important, such
äs family life, relationships and employment.
Many haemophilia patients do not have regulär
employment because of their disability. The per-
centage of patients receiving a disability pension has
increased slightly between 1972 and 1985 from
17% to 22%, although this reflects a decrease when
related to the increased number of disabled persons
in the general population, which more than doubled
in the same period [12, 19, 20]. It is reasonable to
assume that an impairment which removes the
opportunities for certain types of employment may
still allow other paid employment which, for instance,
is less physically demanding. We therefore decided to
investigate possible factors that could affect the risk
of being unemployed due to disability.
Methode
Patients and measurements
The data were collected by standardized mailed
questionnaires sent to all 1162 Dutch haemophiliacs
who were registered at one of the treatment centres
or at the Dutch Haemophilia Society [12]. The
questionnaire covered a broad ränge of topics. The
ciosing date for completion of questionnaires was
Ist January 1986. The treatment centres presented
us with supplementary Information on the type and
severity of haemophilia.
We compared the Information from the patients
with national data after adjustment for age differ-
ences. This comparison was possible for marital
Status [21], number of children [21], evaluation of
one's own health [22], and employment [23], No
data were available on stable relationships in the
general population.
We regarded äs employed those individuals who
held a paid Job. Individuais who are not attending
school may be either economically unemployed and
receive an income from the unemployment funds, or
be disabled and receive a disability pension. When
we speak of disabled individuals we refer to this latter
category, the term disability having a purely ad-
ministrative and not a medical sense. The income
from these funds may be supplementary for indi-
viduals who are still able to participate äs members of
the labour force to some extent: they are disabled
and employed, or even disabled and economically
unemployed. In the case of individuals who are not
regarded äs fit to work at all (administratively less
than 20% working capacity), the disability funds
may provide the only source of income. These
individuals will here be described äs completely
disabled, again in a strictly administrative and not a
medical sense.
With regard to educational level, we used a four-
category classification äs follows: l, lower education
(elementary school); 2, lower additional schooling
(lower vocational training or lower levels of high
school); 3, middle additional schooling (middle vo-
cational training or high school) and; 4, higher
additional schooling (vocational degrees or academic
degrees). Occupational level was classified according
to the Occupational Guide [24] in six categories
(l, uriskilled manual labour; 2, skilled manual
labour; 3, lower employee; 4, small entrepreneur; 5,
middle employee; 6, higher vocation).
Joint impairment for 16 joints was scored äs
follows: 0, no impairment; l, some impairment
without daily problems; 2, impairment with daily
Problems; 3, impairment with complete loss of
function. The scores were added to form a scale
ranging from 0 to 48 points. The number of bleedings
was the total number over a 1-year period preceding
the survey, which was used äs an approximate
estimate for lifetime bleedings.
Analysis
We constructed a logistic regression model to in-
vestigate the independent contribution of several
determinants of disability, i.e. complete disability in
the administrative sense. For this analysis the
patients were regrouped into two non-overlapping
categories: employed (whether partially disabled or
not), and unemployed because of complete disability.
Putative determinants were age, severity of
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haemophilia, inhibitor Status, degree of arthropathy,
number of bleedings, home treatment, educational
level and occupational level.
For this analysis the factors under investigation
were regrouped into a small number of categories äs
follows: flve 10-year age classes; three categories of
severity, according to the usual classification (severe,
<1% clotting factor activity; moderate, 1-5%
clotting factor activity; mild, > 5% clotting factor
activity); three groupings of joint score into tertiles
(0 points, 1-5 points and > 5 points); three cate-
gories of bleeding frequency, also in tertiles (no
bleedings in a year, 1-5 bleedings a year and > 5
bleedings a year); four categories of education äs
outlined above, and four categories of occupational
level (unskilled manual labour, skilled manual
labour/lower employee, small entrepreneur/middle
employee and higher vocation).
First univariate odds and risk ratios on disability
were calculated from simple cross-tabulation. Subse-
quently the variables were entered into the logistic
model, which yielded multivariate odds ratios. Such
a ratio gives a risk estimate which may be regarded
äs the independent contribution of a certain factor to
the total risk, since the other variables have been
held constant.
Results
The response to our survey was 81% (947 forms
returned, of which 935 could be analysed). The
average age of the respondents was 33 years (general
male population 36 years). Forty-one per cent had
severe, 18% had moderately severe and 42% had
mild haemophilia. Eighty-six per cent had haemo-
philia A and 14% had haemophilia B. Among those
with haemophilia A, 40% had severe haemophilia;
among those with haemophilia B, 49% had severe
haemophilia. Comparisons of haemophilia A and B
were therefore weighted for severity. Twenty-two
patients had an inhibitor, in all cases but one to
factor VIII.
Of the patients aged 15 years and older, 49% (363
of 742 patients) were married, while 3.5% (26
patients) were divorced. The proportion of married
men in the general population, after adjustment for
age differences, was 56%, while the number of
divorced men was 3.4%. Therefore the observed/
expected ratio for marriage was 87%, which implies
that the chances of haemophilia patients being
married were reduced by 13% (Table 1). Patients
with haemophilia A and B did not differ significantly
in this respect, and inhibitor patients did not differ
from the other patients with severe haemophilia. By
comparison with the general male population, the
observed/expected ratio (O/E) was lowest for severe
haemophilia (O/E, 76%).
Of all 742 patients aged > 15 years, 211 (28%)
subjects regarded haemophilia äs an impediment to
starting a relationship; 139 (19%) patients also
thought it had a negative effect on the stability of an
existing relationship. Such views were most often
expressed by the patients with severe haemophilia:
44% thought haemophilia was an impediment to
finding a partner, while 27% considered that it had
a negative effect on an existing relationship. Eleven
per cent (67 of 589) of the patients aged ^ 18 years
who had ever had a relationship thought that
haemophilia had once been the cause of such a
relationship ending; again, this was highest in the
case of patients with severe haemophilia (20%).
The 676 patients aged ^18 years had a total of
672 children. The expected number of children for
men of the same age in the general population was
956, i.e. the haemophilia patients had 30% fewer
children (O/E ratio, 0.70). The lower number of
marriages could not entirely account for the low
number of offspring of haemophilia patients: the 363
married patients had a total of 621 children, com-
pared to an expected number of 749. Thus even the
married patients had 17% fewer children than
married men of the same age in the general
population (Table 1). Fourteen per cent of the patients
aged ^20 years without children stated that they
had no children because of haemophilia, the most
frequent reason being that they wished to avoid
passing on the haemophilia gene to their daughters.
Eighty per cent of the patients considered their
own health to be good or excellent (general male
population, 83%). As is shown in Table 2, the
patients with severe, moderate or mild haemophilia
differed only slightly in their opinion of their health.
No differences were observed between patients with
haemophilia A and B. However, the inhibitor patients
more frequently had a negative opinion of their own
health, although 69% still considered their health to
be good or excellent.
One hundred and fifty-five (22%) of the 716
patients aged 15-64 years received an income from
one of the disability funds. In the general male
population 8.3% were disabled (figure corrected for
age differences; unadjusted figure, 11%). Seventy-
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Table 1. Marnages and children of haemophiha patients Table 3. Determmants of disability umvanate analysis
All
Severe
Moderate
Mild
Marned
patients
O/E
087
0 76
087
096
No of children
(all patients)
O/E
0 70
054
056
080
No of children
(marned
patients)
O/E
083
0 74
092
085
The ratio of the observed to expected number (O/E) is shown.
The expected number is that which would be expected in a
group of men of the same age from the general population, i e
it is the population figure corrected for age differences In
haemophilia A the O/E ratio for marnage was 0 88, m
haemophiha B it was 083 The number of marnages refers to
742 patients aged ^15 years, and the number of children
refers to 676 patients aged ^ 18 years, of whom 363 were
marned
Table 2. Responses to the question· 'How do you consider your
own health''
' Good/excellent '
All
Severe
Moderate
Mild
Patients
80
77
80
82
Population
83
86
83
82
' Bad/moderate '
Patients
20
23
20
18
Population
17
14
17
18
The figures apply to individuals aged ^ IS years The
population figures are adjusted for age by weighting to the age
distnbution of the patients Smce patients with severe
haemophiha were on average younger than those with
moderate and mild haemophiha, these figures vary for different
groups For patients with haemophiha A, 80% considered their
own health to be good or excellent, the corresponding figure for
patients with haemophiha B was 79% The population figures
refer to a sample of 1954 Dutch men [22]
five per cent (117 patients) of them were adminis-
tratively completely disabled, and 25% were partially
disabled, i.e. they were receiving an income from one
of the disability funds, in addition to having paid
employment. For most patients (86%) haemophilia
was the cause of their administrative disability.
Disability was most frequently observed in severe
haemophilia (33% äs compared to 7.5% in the
general population, aged-adjusted figure).
We investigated the determinants of this disability
for 534 patients who were either employed
(n = 425) or disabled and unemployed (n = 109).
First, we calculated univariate odds ratios and
relative risks, which are shown in Table 3. Odds
ratios are used äs an approximation of the relative
Factor
Seventy
Mild
Moderate
Severe
Bleedmgs (per year)
0
1-5
> 5
Joint score (points)
0
1-5
> 5
Inhibitor
Absent
Present
Home treatment
No
Yes
Age (years)
15-24
25-34
35-44
45-54
55-64
Education level
Lower
Lower additional
Middle additional
Higher additional
Occupation
Unskilled worker
Skilled worker/lower
employee
Small entrepreneur/
middle employee
Higher vocation
n
230
90
214
222
132
180
148
190
196
521
13
377
157
72
174
161
86
41
86
214
125
90
34
272
142
64
Disabled
(%)
9
22
32
14
18
28
7
12
39
19
62
18
26
6
11
22
31
56
55
18
10
9
29
22
13
6
OR
1 0
30
50
1 0
1 3
2 5
1 0
1 6
79
1 0
6 7
1 0
1 6
1 0
2 1
49
78
21 7
1 0
02
0 1
0 1
1 0
0 7
04
02
RR
1 0
2 6
3 7
10
1 3
2 0
10
1 6
52
10
32
1 0
1 4
1 0
2 0
40
5 7
10 1
10
03
02
02
10
08
0 5
02
The risks of being unemployed due to disability are shown. The
odds ratios (OR) and the nsk ratios (RR) are relative to the
lowest category of each factor, which is set at l 0, e g patients
aged 25-34 years had a nsk of disability twice that for those
aged 15-24 years These odds and risks ratios were calculated
separately for each factor, without taking the other factors mto
account
risk, and should be interpreted äs the risk of being
disabled relative to the lowest category for each
factor. As shown in Table 3, the odds ratios vary in
the same direction of magnitude äs the relative risk,
but remain a rather approximate estimation, due to
the high Proportion of disabled individuals. The
relative risk of disability increased with severity of
haemophilia, age, joint score and number of bleed-
ings. The risk of being disabled was also higher for
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Table 4. Determinante of disabihty logistic regression
Factor
Seventy
Mild
Moderate
Severe
Bleedmgs (per year)
0
1-5
> 5
Jomt score (points)
0
1-5
> 5
Inhibitor
Absent
Present
Home treatment
No
Yes
Age (years)
15-24
25-34
35-14
45-54
55-64
Education
Lower
Lower additional
Middle additional
Higher additional
Occupation
Unskilled worker
Skilled worker/lower
employee
Small entrepreneur/
middle employee
Higher vocation
OR
1 0
4 2
80
1 0
1 1
1 1
10
14
36
1 0
2 9
1 0
05
1 0
3 6
11 0
19 7
1100
1 0
04
02
02
1 0
09
04
02
CI95
1 5 to 1 1 4
2 8 to 23 0
0 4 to 2 6
0 4 to 2 7
0 5 to 4 0
1 2 to 10 7
0 6 to 14 3
0 2 to 1 1
0 4 to 30 2
1 3 to 92 0
2 2 to 172 8
11 2 to 1107 7
0 2 to 0 8
0 1 to 0 6
0 1 to 0 6
0 3 to 2 9
0 1 to 1 4
0 0 to 0 9
These odds ratios (OR) mdicate the independent effect of a
factor The odds ratio estimates the multivanate relative nsk,
e g. when all other factors such äs seventy and jomt score
were controlled for those on home treatment had a nsk of
disabihty 50% of that for patients not on home treatment For
educational and occupational level Information for 37 patients
was missing the odds ratios refer to 497 patients CI95 is the
9 5 % confldence mterval of the odds ratio The odds ratio for
type of haemophilia (A vs B) was exactly l 00
patients on home treatment. However, this risk
ratio is not controlled for severity of haemophilia,
while severe haemophilia is overrepresented among
patients on home treatment.
Subsequently, we calculated multivariate odds
ratios by logistic regression (Table 4). These should
be interpreted äs the risk (approximated by the odds)
relative to the patients within the lowest category for
that variable, while all other factors in the model are
kept constant. For example, severity had an inde-
pendent effect on the risk of being disabled: com-
pared to patients with mild haemophilia, patients
with moderate haemophilia had a 4.2-fold higher
risk of being disabled, while in those with severe
haemophilia it was 8.7-fold higher. The type of
haemophilia was not related to the risk of disability.
When controlled for severity, the presence of an
inhibitor still increased the risk almost threefold.
Home treatment, which in the univariate analysis
had been confounded by severity, reduced the odds
ratio for disability considerably: those patients on
home treatment had a risk of disability only 50% of
that for individuals not on home treatment. A higher
educational level and higher occupational level were
accompanied by a lower risk of disability.
The fit of the model was tested by calculating the
probability of disability for each individual from the
logistic risk function :
P= l/(l+e-')
in which z = α + Σβ
ι
 χ, (χ, is each factor, l when
present and 0 when absent), and P is the probability
of being disabled. For different cut-off points of P we
compared the number of employed and disabled
patients above and below the cut-off points. In this
way the Information about the determinants is used
äs a 'diagnostic test' for disability, and sensitivity
and specificity can be calculated. At a cut-off pomt of
P = 0.13, sensitivity was 0.95 and specificity was
0 74 (predictive value 45 %). Given these figures, we
conclude that the model is a fairly reliable predictor
of disability, despite the approximate nature of some
of the estimates, such äs the bleeding frequency and
arthropathy.
Discussion
The availability of coagulation products for the
treatment of haemophilia has greatly improved the
quality of daily life of haemophilia patients m the
Netherlands. Further improvement may be expected,
äs an increasingly large number of patients will have
received adequate treatment from childhood onward.
It has been suggested that, even though haemophilia
A and B have identical natural histories [25, 26],
differences in treatment might eventually result in a
different clinical presentation of both states [25]. In
this study, however, we found no difference between
haemophilia A and B. Inhibitor patients have bene-
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fited least from Substitution therapy. Therefore, the
management of these patients will remain one of the
major challenges of haemophilia treatment.
Since the early days of Substitution treatment, the
aim in haemophilia care has shifted from the
treatment of severe bleedings alone to the prevention
of the sequelae of bleedings, notably arthropathy.
This implies prompt treatment of bleedings with
adequate dosage [27-30]. In a recent consensus
meeting on haemophilia treatment, the Dutch
haematologists emphasized that treatment of joint
bleedings at the first sign, and within at least 2 h
after onset, may be of paramount importance in the
prevention of joint damage [31, 32]. In patients with
a high bleeding frequency, i.e. more than one bleed
per week, prophylactic treatment should be con-
sidered. Home treatment should be encouraged
because it ensures early treatment, increases in-
dependence and maximizes opportunities for school-
ing and employment. Haemophilia care should pref-
erably be performed or supervised by specialized
centres with comprehensive care teams, which im-
plies involvement of Professionals from different fields.
At present, the physical well-being of many
haemophilia patients is threatened by AIDS. In this
respect, our study demonstrates the benefits of
modern haemophilia care, but predominantly for
those patients who escaped HIV infection. In the
Netherlands, about 17% of haemophilia patients are
HIV positive [33]. This implies that here and in other
countries with a low prevalence of seropositivity,
such äs Belgium [34, 35], Norway [36] and Finland
(Ikkala, personal communication), many patients
will already be receiving the füll benefit of the
improvements reported here. However, even in the
countries with the highest HIV seroprevalence, AIDS
among haemophilia patients will be a temporary
tragedy. For those countries our study is of both
historical and future relevance, for it demonstrates
the benefits that may be expected after this tragedy of
AIDS has passed.
Family life and employment are the most promi-
nent features of daily life. It is obvious that before
clotting products became available, when patients
usually did not survive beyond early adulthood [13],
few had the opportunity for stable relationships or
employment. At present, the difference between
haemophilia patients and the general population is
small. Haemophilia still poses some barriers to the
Initiation of relationships, but most patients are able
to overcome these problems.
Haemophilia patients had fewer children than
men of the same age in the general population, and
this was the case even for those who were married.
Of necessity, however, these data refer to older
patients, many of whom have not benefited from
adequate replacement therapy from childhood on-
ward.
As we have reported previously, haemophilia
patients were less frequently unemployed for econ-
omical reasons alone than the average Dutch male
[37]. Furthermore, the patients who were employed
had obtained positions in employment that were
appropriate to the education they had received, and
they did not have to perform Jobs below their level of
ability. Equally encouraging was the observation
that the educational level of haemophilia patients in
The Netherlands was the same äs that of the general
population [12, 38]. In the present study we found
that severity of haemophilia and joint damage were
factors that increased the probability of being disabled
in an administrative sense, while home treatment
reduced this probability. We have the firm Impression
that modern replacement therapy prevents or at least
slows the rate of progression of arthropathy, and that
if effectively prevents many other problems related to
the severity of haemophilia. This justifies the ex-
pectation that increasing numbers of haemophilia
patients will succeed in obtaining employment. It is
readily understood that home treatment—which
might in this case perhaps be more accurately termed
'factory or office treatment', since patients also
administer transfusions at their place of work—is of
practical importance in facilitating employment.
Although these figures should be regarded with a
certain degree of caution, since the analysis was
performed on patients who were ' administratively
disabled', a prevalent Status which may already have
existed for years, the determinants in our model
proved to be remarkably discriminatory. If modern
haemophilia treatment leads to the expected pre-
vention of progression of joint damage, we will in the
future see a decrease in unemployment because of
disability.
Quality of life remains an ill-defined subject. In a
similar study, patients with end-stage renal disease
were asked to assess their own quality of life by
means of several questionnaires that had also been
used in the general population. However, these
subjective quality assessments correlated poorly with
objective measurements, äs functional impairment
and ability to work. Moreover, the results showed
MODERN HAEMOPHILIA TREATMENT 639
that these chronically ill patients were almost äs
satisfied with the quality of their lives äs healthy
people. This led to the conclusion that, despite a
serious illness, satisfaction can be reached through a
normal process of adaptation [39, 40]. It appeared
that the patients rated their own quality of life higher
than it would be assessed by others, which raises the
following question: 'quality according to whom?'
To paraphrase a commercial slogan, 'a man is äs
healthy äs he feels'. In this respect, haemophilia
patients differ very little from the general population,
and most patients consider themselves to be in good
or excellent health. This may be the most promising
observation of all, for if patients with haemophilia
are able to maintain the view that they are äs fit äs
any other individual, and are no different from
them, they will succeed in founding families, finding
employment and overcoming the remaining prob-
lems that face them.
Acknowledgements
We wish to thank the patients and the Dutch
haemophilia centre directors for their cooperation.
This study was supported by grants from Het
Praeventiefonds (28-1099) and De Stichting Hae-
mophilia.
References
1 Pool JG. Shannon AE. Production of high potency concentrates
of antihcmophilic globulin in a closed bag System. N Engl
l Mcd 1965: 273: 1443-7.
2 Soulier JP, Blatrix Ch. Steinbuch M. Fractions 'coagulantes'
contenant les facteurs de coagulation adsorbables par le
Phosphate tricalcique. Presse Med 1964; 72: 1223-8.
3 Loeliger EA. Hensen A, Mattern MJ, Veitkamp JJ, Brunning PF,
Hemker HC. Treatment of haemophilia B with purifled Factor
IX (PPSB). Folia Med Neerl 1967; 10: 112-25.
4 Meijer K, Eernisse JG. Veitkamp JJ, Hemker HC. Loeliger EA.
Treatment of haemophilia A with purifled Factor VIII obtained
from plasma by cryoprecipitation. Folia Med Neerl 1967;
10: 49-60.
5 Biggs R. Haemophilia treatment in the United Kingdom from
1969 to 1974. Br J Haematol 1977; 35: 487-504.
6 Rizza CR, Spooner RJD. Treatment of haemophilia and related
disorders in Britain and Northern Ireland during 1976-1980:
report on behalf of the directors of haemophilia centres in the
United Kingdom. Br Med ] 1983; 286: 929-33.
7 Veitkamp JJ. Schrijver G, Willeumier W, Van de Putte B, Van
Dijck H. Hemophilia in the Netherlands: results of a survey on
the medical. genetic and social Situation of the Dutch
hemophiliacs. Acta Med Scand 1974; (Suppl. 572): 1-24.
8 Robinson PM, Tittley ART, Smiley RK. Prophylactic therapy
in classical hemophilia: a preliminary report. Can Med Assoc J
1967; 97: 559-61.
9 Nilsson IM, Blombäck M. Ahlberg Ä. Our experience in Sweden
with prophylaxis on haemophilia. Bibl Haematol 1970; 34:
111-24.
10 Rabiner SF, Telfer MC. Home transfusions for patients with
hemophilia. N Engl J Med 1970; 283: 1011-5.
11 Levine PH. Efflcacy of self-therapy in hemophilia: a study of
72 patients with hemophilia A and B. N Eng J Med 19 74; 291:
1381-4.
12 Smit C, Rosendaal FR, Varekamp I et al. Physical condition,
longevity, and social Performance of Dutch haemophiliacs,
1972-1985. Br Med J 1989; 298: 235-8.
13 Larsson SA. Life expectancyof Swedish haemophiliacs, 1831-
1980. Br/ Haematol 1985; 59: 593-602.
14 Rosendaal FR, Varekamp I, Smit C et al Mortality and causes
ofdeath in Dutch haemophiliacs, 1973-1986. Br J Haematol
1989; 71: 71-6.
15 Campbell A, Converse PE, Rodgers WL. The Quality of American
Life. New York: Russell Sage, 1976.
16 Szalai A. The meaning of comparative research on the quality
of life. In: Szalai A, Andrew FM. eds. The Quality of Life:
Comparative Studies. London: Russell Sage, 1980; 7-21.
17 Suurmeijer TPBM. Social aspects of hemophilia. In: Smit
Sibinga CT, Das PC, Van Loghem JJ, eds. Blood Transfusion and
Problems of Bleeding. The Hague: Martinus Nijhof, 1982;
207-18.
18 De Haes JCJM. Kwaliteit van leven van kankerpatienten
(quality of life of patients with cancer). Thesis. Leiden 1988.
19 Sociaal en Cultureel Planbureau. Sociaal en cultureel rapport
1986. The Hague: Staatsuitgeverij, 1986.
20 Department of Social Affairs. Labour Market Report 1985
(Rapportage Arbeidsmarkt 1985). The Hague: Staatsuitgeverij,
1985.
21 Beets GCN, De Graaf A. Relation« and childbearing in 1983.
Mndstat bevolk (Central Bureau of Statistics, The Hague)
1985; 1: 53-62.
22 Central Bureau of Statistics. The Life Situation of the Dutch
Population, 1983: Central Figures (De Leefsituatie van de
Nederlandse Bevolking, 1983: Kerncijfers). The Hague:
Staatsuitgeverij, 1984; Table 5.13.
23 National Community Medical Service (Gemeenschappelijke
Medische Dienst). Annual Report 1985. Amsterdam: GMD,
1985.
24 Kropman L. Occupational Guide (Beroepenklapper). Nijmegen:
Institute for Applied Sociology, 1975.
2 5 Ramgren 0. A clinical and medico-social study of haemophilia
in Sweden. Acta Med Scand 1962; 171 (Suppl. 379): 111-90.
26 Ahlberg Ä. Incidence, treatment and prophylaxis of arthro-
pathy and other musculoskeletal manifestations of haemo-
philia A and B. Acta Orthop Scand 1965: (Suppl. 77): 3-132.
27 Allain JP. Dosage requirements for Substitution therapy in
hemophiliacs. Scand J Haematol 1980; 35: 29^6.
28 Levine PH. Clinical manifestations and therapy of hemophilias
A and B. In: Colman RW, Hirsch J, Marder VJ, Salzman EW,
eds. Hemostasis and Thrombosis: Basic Principles and Clinical
Practice. Toronto: üppincott, 1987; 97-111.
29 Rizza CR, Jones P. Management of patients with inherited
blood coagulation defects. In: Bloom AL. Thomas DP, eds.
Haemostasis and Thrombosis. New York: Churchill Livingstone,
1987; 465-93.
30 Kasper CK, Dietrich SL. Comprehensive management of
haemophilia. Clin Haematol 1985; 14: 489-512.
31 Briet E, Breederveld C. Consensus hemofiliebehandeling. Ned
Tijdschr Geneeskd 1987; 131: 1914-6.
640 F. R. ROSENDAAL et al Jour
32 Voorbereidmgswerkgroep Consensus-Bijeenkomst Behandehng
Hemofihe (Consensus Meeting Haemophiha Treatment) Utrecht
Centraal Begeleidmgsorgaan voor de Intercollegiale toetsing
(ISBN 90-6910-040-1CP) , 1987, 1-81
33 Rosendaal FR, Srait C, Varekamp I, Brocker-Vnends A,
Suurmeijer T, Briet E AIDS and haemophilia a study among
Dutch haemophihacs on the psychological impact of the AIDS
threat, the prevalence of HIV antibodies and the adoption of
measures to prevent HIV mfection Haemostasis 1988, 18:
73-82
34 Rouzioux C Brun-Venizet F, Courouce AM et al Immuno-
globulm G antibodies to lymphadenopathy-associated virus
in differently treated French and Belgien hemophihacs Arm
Intern Med 1985. 102: 476-9
35 Haeraophilia study group Haemophilia, HIV mfection, and
blood transfusion in Belgium Acta Chn Belg 1988, 43:
95-100
36 Evensen SA Ulstrup J, Skaug K, Fröland SS, Glomsttin A,
Rollag H HIV mfection m Norwegian haemophiliacs the
_ prevalence of antibodies agamst HIV m haemophiliacs treated
with lyophihzed cryoprecipitate from volunteer donors Eur
JHaematol 1987, 39: 44^8
37 Varekamp I, Smit C, Rosendaal FR et al Employment of
individuals with haemophilia m the Netherlands Soc Sei Med
1989, 28: 261-70
38 Varekamp I Rosendaal FR, Smit-Van Dijck HC, Brocker-
Vnends A, Suurmeijer TPBM, Briet E De maatschappehjke
effecten van de moderne hemoflliebehandelmg Ned Tijdsch
Geneeskd 1989, 133: 404-8
39 Evans RW, Mannmen DL, Garnson LP et al The quality of life
of patients with end-stage renal disease N Engl } Med 1985,
312: 553-9
40 Gutman RA High-cost life Prolongation the national kidney
dialysis and kidney transplantation study Ann Intern Med
1988, 108:898-9
Received 14 February 1990, accepted 5 April 1990
Correspondence F R Rosendaal, MD, Department of Clmical Epi-
demiology, Building l, CO-P-46. Umversity Hospital Leiden, P 0
Box 9600, 2300 RC Leiden, The Netherlands
Tr
Intrc
36
